Peter has partnered with Answer ALS, a groundbreaking, collaborative, multi-institutional research program that is paving the way for a more hopeful prognosis for future ALS patients. He is confident that his involvement will help end this disease. But to do that, he needs your help.
In August 2015, Peter Warlick was diagnosed with ALS, a progressive neurodegenerative disease. Today, there is no known cure for ALS, yet there are reasons to be hopeful. Recent advances now offer hope for a better understanding of the disease’s mechanisms and the development of more effective treatments. While these advancements may not have an immediate impact on his battle, Peter has launched Warlick’s Warriors in an effort to help fund Answer ALS.
Answer ALS is a collaborative, multi-institutional research program led by Johns Hopkins University, Harvard Mass General Hospital, and Cedars-Sinai Medical Center, along with other leading institutions. Answer ALS plans to enroll 1000+ ALS patients in this groundbreaking study and Peter is proud to be among the first one hundred patients enrolled. He is confident that his involvement will end this disease for future generations. But to do that, he needs your help.